Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Retrospective Studies [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
IS1 [NCBI] 0.012459
VRNI [NCBI] 0.0117784
KLK3 [NCBI] 0.00495147
SLE [NCBI] 0.0017178
chiari malformation type i [NCBI] 0.00153555
CEACAM5 [NCBI] 0.00150592
temporal arteritis [NCBI] 0.00149001
thrombocytopenic purpura, autoimmune [NCBI] 0.00133584
lymphoma, non-hodgkin, familial [NCBI] 0.00129634
palatopharyngeal incompetence [NCBI] 0.00110951
OD [NCBI] 0.00104221
HFM [NCBI] 0.000963599
AFP [NCBI] 0.000872445
apnea, obstructive sleep [NCBI] 0.000803134
MG [NCBI] 0.000795827
CFEOM3A [NCBI] 0.000626994
CPD2 [NCBI] 0.000626994
MCOPS10 [NCBI] 0.000626994
behcet syndrome [NCBI] 0.000591329
CRC [NCBI] 0.000584334
jejunal atresia [NCBI] 0.000553281
NNO1 [NCBI] 0.000553281
glaucoma-related pigment dispersion syndrome [NCBI] 0.000534527
PCNA [NCBI] 0.000497943
TG [NCBI] 0.000472796
DWS [NCBI] 0.000447485
alzheimer disease 5 [NCBI] 0.000437914
DFSP [NCBI] 0.000426543
SRS [NCBI] 0.000395896
IDDM [NCBI] 0.000395896
primary lateral sclerosis, adult [NCBI] 0.000369123
FTSD [NCBI] 0.000369123
TS [NCBI] 0.000356789
centralopathic epilepsy [NCBI] 0.000355889
EGF [NCBI] 0.000320732
PTH [NCBI] 0.000287067
NGFB [NCBI] 0.00028062
axenfeld-rieger anomaly with cardiac defects and sensorineural hearing loss [NCBI] 0.000276365
osteogenesis imperfecta, type v [NCBI] 0.000276365
AVSD [NCBI] 0.000258289
LAM [NCBI] 0.000257442
EGFR [NCBI] 0.000250066
leber optic atrophy, susceptibility to [NCBI] 0.000244094
CF [NCBI] 0.000236388
NPY [NCBI] 0.000227406
thyroid carcinoma, hurthle cell [NCBI] 0.000218705
RP6 [NCBI] 0.000218705
RP24 [NCBI] 0.000218705
sneddon syndrome [NCBI] 0.000218705
VEGF [NCBI] 0.000210175
CMTC [NCBI] 0.000193821
TYMS [NCBI] 0.000186371
TH [NCBI] 0.000180037
larsen syndrome, recessive [NCBI] 0.000177714
CDAN2 [NCBI] 0.000170627
hemangioma-thrombocytopenia syndrome [NCBI] 0.000166356
aortic valve disease [NCBI] 0.000161126
PGR [NCBI] 0.000158726
EIG [NCBI] 0.000150195
FA [NCBI] 0.00014759
hemangioma, capillary infantile [NCBI] 0.000146542
neutrophilic dermatosis, acute febrile [NCBI] 0.000146542
PGL2 [NCBI] 0.000146542
MUC1 [NCBI] 0.000146452
KRT20 [NCBI] 0.000144373
VUR1 [NCBI] 0.000142698
APC [NCBI] 0.000142637
PCD [NCBI] 0.000123341
VIP [NCBI] 0.000121882
MYMY1 [NCBI] 0.000121857
BRCD1 [NCBI] 0.000121857
schimmelpenning-feuerstein-mims syndrome [NCBI] 0.000121857
TAPVR1 [NCBI] 0.000121857
NYS2 [NCBI] 0.000121857
diarrhea 2, with microvillous atrophy [NCBI] 0.000121857
FTD [NCBI] 0.000115868
OCP [NCBI] 0.000111825
melanoma, uveal [NCBI] 0.000111675
ACPP [NCBI] 0.00010813
klippel-trenaunay-weber syndrome [NCBI] 0.00010759
GIST [NCBI] 0.000106455
MCOPS1 [NCBI] 0.000101785
pulmonary disease, chronic obstructive [NCBI] 0.000101785
CVS [NCBI] 9.70745e-05
EPO [NCBI] 9.39373e-05
CRMO [NCBI] 9.32362e-05
TRS [NCBI] 9.23793e-05
CPI [NCBI] 9.19386e-05
RTT [NCBI] 9.10512e-05
MBP [NCBI] 9.10235e-05
TSD [NCBI] 8.99871e-05
BDNF [NCBI] 8.83424e-05
MJD [NCBI] 8.53068e-05
mohr syndrome [NCBI] 8.51606e-05
CDB2 [NCBI] 8.51606e-05
GCY [NCBI] 8.51606e-05
DMD [NCBI] 8.23242e-05
myeloproliferative syndrome, transient [NCBI] 8.16603e-05
NPPA [NCBI] 8.15391e-05
PWS [NCBI] 7.64253e-05
CAT [NCBI] 7.55438e-05
JMML [NCBI] 7.51136e-05
MODY [NCBI] 7.46276e-05
CJD [NCBI] 7.40308e-05
dystrophia myotonica 1 [NCBI] 7.40069e-05
SLOS [NCBI] 7.33722e-05
LSA [NCBI] 7.33185e-05
AT [NCBI] 7.22196e-05
fragile x mental retardation syndrome [NCBI] 7.13242e-05
corneal dystrophy, crystalline, of schnyder [NCBI] 7.12132e-05
CCK [NCBI] 6.82132e-05
CRH [NCBI] 6.80838e-05
IFNA1 [NCBI] 6.58886e-05
felty syndrome [NCBI] 6.47895e-05
caroli disease, isolated [NCBI] 6.47895e-05
minicore myopathy, antenatal onset, with arthrogryposis [NCBI] 6.47895e-05
optic nerve hypoplasia, bilateral [NCBI] 6.45832e-05
AS [NCBI] 6.28902e-05
FSHMD1A [NCBI] 6.16499e-05
TNF [NCBI] 6.06828e-05
WDM [NCBI] 5.94045e-05
sjogren syndrome [NCBI] 5.94045e-05
CMM [NCBI] 5.75077e-05
bartter syndrome, infantile, with sensorineural deafness [NCBI] 5.6292e-05
PPNAD1 [NCBI] 5.6292e-05
LKS [NCBI] 5.02305e-05
hypophosphatemic rickets, x-linked dominant [NCBI] 5.02305e-05
AIMAH [NCBI] 4.84461e-05
apert syndrome [NCBI] 4.62206e-05
ACHE [NCBI] 4.49037e-05
rheumatoid arthritis, systemic juvenile [NCBI] 4.42867e-05
PGL4 [NCBI] 4.42867e-05
AD [NCBI] 4.12752e-05
PCLD [NCBI] 4.12374e-05
ALB [NCBI] 4.08751e-05
FEB1 [NCBI] 4.07392e-05
CBBM [NCBI] 4.07392e-05
factor v deficiency [NCBI] 4.06692e-05
IS [NCBI] 3.97089e-05
ABCB4 [NCBI] 3.96844e-05
FMF [NCBI] 3.94186e-05
EV [NCBI] 3.91428e-05
MS [NCBI] 3.91428e-05
CAPN3 [NCBI] 3.89588e-05
hemophagocytic lymphohistiocytosis, familial, 1 [NCBI] 3.85951e-05
retinopathy, pericentral pigmentary, autosomal recessive [NCBI] 3.78209e-05
hypomyelination and congenital cataract [NCBI] 3.78209e-05
teeth present at birth [NCBI] 3.78209e-05
papillary thyroid microcarcinoma [NCBI] 3.78209e-05
bothnia retinal dystrophy [NCBI] 3.78209e-05
lissencephaly type iii and bone dysplasia [NCBI] 3.78209e-05
MCOPCB4 [NCBI] 3.78209e-05
thymic-renal-anal-lung dysplasia [NCBI] 3.78209e-05
epilepsy with bilateral occipital calcifications [NCBI] 3.78209e-05
CD [NCBI] 3.70264e-05
DHFR [NCBI] 3.69003e-05
EVA [NCBI] 3.66078e-05
DRPLA [NCBI] 3.55164e-05
FRDA [NCBI] 3.54223e-05
HHF2 [NCBI] 3.4569e-05
pena-shokeir syndrome, type i [NCBI] 3.41684e-05
HGF [NCBI] 3.34684e-05
MYP2 [NCBI] 3.33659e-05
myeloma, multiple [NCBI] 3.23401e-05
coloboma, ocular [NCBI] 3.23401e-05
AVP [NCBI] 3.22697e-05
CCNE1 [NCBI] 3.21378e-05
ALPS [NCBI] 3.17683e-05
PTK2 [NCBI] 3.1502e-05
giant platelet syndrome [NCBI] 3.05664e-05
acyl-coa dehydrogenase, medium-chain, deficiency of [NCBI] 3.0128e-05
EFE [NCBI] 3.0128e-05
BCNS [NCBI] 2.99176e-05
ALK [NCBI] 2.96542e-05
SCA1 [NCBI] 2.93733e-05
CDA [NCBI] 2.93145e-05
CFH [NCBI] 2.89482e-05
TPMT [NCBI] 2.87112e-05
DGS [NCBI] 2.85343e-05
SEDC [NCBI] 2.83156e-05
WHS [NCBI] 2.81891e-05
CD [NCBI] 2.81891e-05
coats disease [NCBI] 2.81431e-05
aneurysmal bone cysts [NCBI] 2.81431e-05
coloboma of optic nerve [NCBI] 2.81431e-05
pseudopapilledema [NCBI] 2.81431e-05
phace association [NCBI] 2.81431e-05
ventricular tachycardia, familial [NCBI] 2.81431e-05
HJMD [NCBI] 2.81431e-05
basal cell carcinoma, multiple [NCBI] 2.81431e-05
anemia, autoimmune hemolytic [NCBI] 2.81431e-05
LVNCX [NCBI] 2.81431e-05
LPL [NCBI] 2.76535e-05
POMC [NCBI] 2.76119e-05
NF1 [NCBI] 2.75566e-05
PAND1 [NCBI] 2.70476e-05
XFS [NCBI] 2.66243e-05
LCA1 [NCBI] 2.66126e-05
BWS [NCBI] 2.64539e-05
PPARA [NCBI] 2.63983e-05
urogenital adysplasia, hereditary [NCBI] 2.63532e-05
PPR [NCBI] 2.63532e-05
ZS [NCBI] 2.58495e-05
APS1 [NCBI] 2.58495e-05
RA [NCBI] 2.57579e-05
WAS [NCBI] 2.46578e-05
RB1 [NCBI] 2.44741e-05
BHD [NCBI] 2.42153e-05
ARMD4 [NCBI] 2.42153e-05
kaposi sarcoma [NCBI] 2.42153e-05
F3 [NCBI] 2.35554e-05
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 2.33163e-05
PJS [NCBI] 2.31886e-05
ALD [NCBI] 2.29668e-05
HBB [NCBI] 2.21628e-05
bile acid synthesis defect, congenital, 1 [NCBI] 2.21407e-05
isotretinoin embryopathy-like syndrome [NCBI] 2.21407e-05
CAMT [NCBI] 2.21407e-05
pars planitis [NCBI] 2.21407e-05
MVP [NCBI] 2.0792e-05
WRN [NCBI] 2.0742e-05
GAPDH [NCBI] 2.0387e-05
ASPS [NCBI] 2.00819e-05
thrombasthenia of glanzmann and naegeli [NCBI] 1.96401e-05
IFI44 [NCBI] 1.92453e-05
MDD [NCBI] 1.9228e-05
TF [NCBI] 1.86827e-05
MTHFR [NCBI] 1.85943e-05
AMFR [NCBI] 1.84638e-05
AIS [NCBI] 1.81816e-05
CHS [NCBI] 1.81816e-05
PPCRA [NCBI] 1.78839e-05
recombinant chromosome 8 syndrome [NCBI] 1.78839e-05
FCDT [NCBI] 1.78839e-05
hypotension, orthostatic [NCBI] 1.78839e-05
ovarian cancer, epithelial [NCBI] 1.78839e-05
NAIC [NCBI] 1.78839e-05
WARBM [NCBI] 1.78839e-05
respiratory distress syndrome in premature infants [NCBI] 1.78839e-05
melanoma-pancreatic cancer syndrome [NCBI] 1.78839e-05
PGL3 [NCBI] 1.78839e-05
LVNC1 [NCBI] 1.78839e-05
GRA [NCBI] 1.78469e-05
PRL [NCBI] 1.77358e-05
CCD [NCBI] 1.74772e-05
LGMD2A [NCBI] 1.7128e-05
PYY [NCBI] 1.70005e-05
AMC [NCBI] 1.69637e-05
PEE1 [NCBI] 1.69441e-05
APOB [NCBI] 1.62044e-05
HCH [NCBI] 1.60533e-05
VDR [NCBI] 1.60411e-05
SHBG [NCBI] 1.58842e-05
ADAMTS13 [NCBI] 1.56902e-05
sandhoff disease [NCBI] 1.50357e-05
CVID [NCBI] 1.48691e-05
CTGF [NCBI] 1.46775e-05
nonarteritic anterior ischemic optic neuropathy, susceptibility to [NCBI] 1.46551e-05
methylmalonic aciduria, cbla type [NCBI] 1.46551e-05
corneal dystrophy, epithelial basement membrane [NCBI] 1.46551e-05
ectopia lentis, isolated [NCBI] 1.46551e-05
basal ganglia disease, adult-onset [NCBI] 1.46551e-05
peters anomaly [NCBI] 1.46551e-05
DFNA11 [NCBI] 1.46551e-05
HOA [NCBI] 1.46551e-05
asthma, susceptibility to [NCBI] 1.43468e-05
GFAP [NCBI] 1.42813e-05
INPP1 [NCBI] 1.42296e-05
SLC25A15 [NCBI] 1.42296e-05
MBL2 [NCBI] 1.41495e-05
menkes disease [NCBI] 1.38397e-05
KTCN1 [NCBI] 1.38195e-05
CMH [NCBI] 1.37516e-05
hypercholesterolemia, autosomal dominant [NCBI] 1.37516e-05
BIRC1 [NCBI] 1.32279e-05
metachromatic leukodystrophy [NCBI] 1.28395e-05
HP [NCBI] 1.2829e-05
SLC25A19 [NCBI] 1.27858e-05
DIO3 [NCBI] 1.27858e-05
CRK [NCBI] 1.27858e-05
CCNE2 [NCBI] 1.27858e-05
HOXB7 [NCBI] 1.27858e-05
PF4 [NCBI] 1.27821e-05
ADA [NCBI] 1.26903e-05
histidinemia [NCBI] 1.25676e-05
PCOS1 [NCBI] 1.25444e-05
LPI [NCBI] 1.23465e-05
aHUS [NCBI] 1.2293e-05
GCDH [NCBI] 1.21421e-05
EDN3 [NCBI] 1.21421e-05
legg-calve-perthes disease [NCBI] 1.21057e-05
avascular necrosis of femoral head, primary [NCBI] 1.21057e-05
BFH [NCBI] 1.21057e-05
HOMG3 [NCBI] 1.21057e-05
pneumothorax, primary spontaneous [NCBI] 1.21057e-05
MEN2A [NCBI] 1.18585e-05
ADHD [NCBI] 1.17148e-05
CXADR [NCBI] 1.16472e-05
bsnd gene [NCBI] 1.16472e-05
TNFRSF10D [NCBI] 1.16472e-05
HSPA1L [NCBI] 1.16472e-05
amyloidosis vi [NCBI] 1.15603e-05
CCND1 [NCBI] 1.1212e-05
WBS [NCBI] 1.09944e-05
IGFALS [NCBI] 1.08301e-05
HPS [NCBI] 1.07503e-05
TPM2 [NCBI] 1.07105e-05
EMP2 [NCBI] 1.07105e-05
EPHX1 [NCBI] 1.06594e-05
SPP1 [NCBI] 1.05894e-05
GJB2 [NCBI] 1.04152e-05
BCL6 [NCBI] 1.03927e-05
MFS [NCBI] 1.03771e-05
sudden infant death syndrome [NCBI] 1.03562e-05
glycogen storage disease i [NCBI] 1.01347e-05
NPHP2 [NCBI] 1.00392e-05
BPP [NCBI] 1.00392e-05
globozoospermia [NCBI] 1.00392e-05
kuru, susceptibility to [NCBI] 1.00392e-05
EKD1 [NCBI] 9.93801e-06
CLDN4 [NCBI] 9.91705e-06
VKORC1 [NCBI] 9.91705e-06
PODXL [NCBI] 9.91705e-06
YWHAE [NCBI] 9.91705e-06
NLS [NCBI] 9.86926e-06
DES [NCBI] 9.4086e-06
GRN [NCBI] 9.4086e-06
GHRH [NCBI] 9.39733e-06
TK2 [NCBI] 9.23085e-06
GRHPR [NCBI] 9.23085e-06
BCL10 [NCBI] 9.23085e-06
RPL19 [NCBI] 9.23085e-06
MKS1 [NCBI] 9.0448e-06
LQT1 [NCBI] 9.0448e-06
BRAF [NCBI] 8.7464e-06
AMACR [NCBI] 8.7464e-06
CHH [NCBI] 8.73349e-06
gaucher disease, type i [NCBI] 8.73349e-06
MALT1 [NCBI] 8.62786e-06
TNNI2 [NCBI] 8.62786e-06
LI1 [NCBI] 8.59873e-06
gaucher disease, type iii [NCBI] 8.47804e-06
TNFSF6 [NCBI] 8.39601e-06
complement factor i deficiency [NCBI] 8.33369e-06
GS2 [NCBI] 8.33369e-06
VLDLRCH [NCBI] 8.33369e-06
ACG2 [NCBI] 8.33369e-06
DDD [NCBI] 8.33369e-06
LRS1 [NCBI] 8.33369e-06
iron overload in africa [NCBI] 8.33369e-06
carnitine palmitoyltransferase ii deficiency, lethal neonatal [NCBI] 8.33369e-06
fabry disease [NCBI] 8.32023e-06
PD [NCBI] 8.10803e-06
SEMA3B [NCBI] 8.09135e-06
HPR [NCBI] 8.09135e-06
CLDN3 [NCBI] 8.09135e-06
PTPRO [NCBI] 8.09135e-06
CBFB [NCBI] 8.09135e-06
VWS [NCBI] 7.72016e-06
CHM [NCBI] 7.72016e-06
PTGS2 [NCBI] 7.66487e-06
hepatocellular carcinoma [NCBI] 7.6467e-06
FUR [NCBI] 7.60918e-06
GNPAT [NCBI] 7.60918e-06
DGUOK [NCBI] 7.60918e-06
ITPA [NCBI] 7.60918e-06
FLCN [NCBI] 7.60918e-06
GJA1 [NCBI] 7.39526e-06
ALGS1 [NCBI] 7.37901e-06
ACADM [NCBI] 7.19555e-06
CLCN7 [NCBI] 7.17224e-06
SFRP4 [NCBI] 7.17224e-06
RECK [NCBI] 7.17224e-06
KRT8 [NCBI] 7.17224e-06
TNFRSF11B [NCBI] 7.06645e-06
CSF3 [NCBI] 7.06639e-06
LDLR [NCBI] 6.97288e-06
hypouricemia, renal [NCBI] 6.9084e-06
corneal dystrophy, gelatinous drop-like [NCBI] 6.9084e-06
severe cutaneous adverse reaction, susceptibility to [NCBI] 6.9084e-06
erythermalgia, primary [NCBI] 6.9084e-06
DA1 [NCBI] 6.9084e-06
hepatitis b virus, susceptibility to [NCBI] 6.9084e-06
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome [NCBI] 6.9084e-06
FMD [NCBI] 6.9084e-06
keratitis-ichthyosis-deafness syndrome, autosomal dominant [NCBI] 6.9084e-06
AGT [NCBI] 6.90336e-06
thyroid carcinoma, papillary [NCBI] 6.81764e-06
LWD [NCBI] 6.81764e-06
NQO1 [NCBI] 6.77357e-06
BRCA1 [NCBI] 6.74874e-06
MAS [NCBI] 6.60717e-06
LRP1 [NCBI] 6.51427e-06
CFTR [NCBI] 6.46684e-06
SSX1 [NCBI] 6.40768e-06
FOLR1 [NCBI] 6.40768e-06
NOTCH3 [NCBI] 6.40768e-06
CD14 [NCBI] 6.40768e-06
NEFH [NCBI] 6.40768e-06
CGA [NCBI] 6.40768e-06
FGF7 [NCBI] 6.34246e-06
CP [NCBI] 6.308e-06
F2 [NCBI] 6.29064e-06
REN [NCBI] 6.29064e-06
INVS [NCBI] 6.07018e-06
MMP7 [NCBI] 6.07018e-06
PKHD1 [NCBI] 6.07018e-06
ACE [NCBI] 6.03062e-06
PGF [NCBI] 5.75753e-06
THBD [NCBI] 5.75753e-06
TPH1 [NCBI] 5.75753e-06
SLC19A1 [NCBI] 5.75753e-06
ATF1 [NCBI] 5.75753e-06
CYP2C9 [NCBI] 5.75753e-06
MTND4 [NCBI] 5.73467e-06
WSS [NCBI] 5.70698e-06
CDL1 [NCBI] 5.70698e-06
OCD1 [NCBI] 5.70698e-06
GPI [NCBI] 5.69795e-06
RP [NCBI] 5.67669e-06
HHT [NCBI] 5.65664e-06
down syndrome [NCBI] 5.65664e-06
sickle cell anemia [NCBI] 5.65664e-06
STGD1 [NCBI] 5.51945e-06
CRX [NCBI] 5.46679e-06
RTN4 [NCBI] 5.46679e-06
CBR1 [NCBI] 5.46679e-06
NSD1 [NCBI] 5.46679e-06
MIF [NCBI] 5.46679e-06
ACP5 [NCBI] 5.39974e-06
wilson disease [NCBI] 5.3385e-06
TFPI [NCBI] 5.31102e-06
NF2 [NCBI] 5.31077e-06
BRRS [NCBI] 5.26822e-06
FRAP1 [NCBI] 5.20769e-06
EXT2 [NCBI] 5.19553e-06
ADSL [NCBI] 5.19553e-06
ANGPT2 [NCBI] 5.19553e-06
MB [NCBI] 5.18754e-06
SPINK1 [NCBI] 5.18474e-06
ACH [NCBI] 5.05224e-06
PXE [NCBI] 5.03467e-06
alport syndrome, autosomal dominant [NCBI] 4.95402e-06
MMP12 [NCBI] 4.94168e-06
ABCC1 [NCBI] 4.92539e-06
CSA [NCBI] 4.8887e-06
osteogenesis imperfecta, type iia [NCBI] 4.8887e-06
protein c deficiency, congenital thrombotic disease due to [NCBI] 4.87764e-06
MAP2 [NCBI] 4.86794e-06
GTS [NCBI] 4.7865e-06
HRPT2 [NCBI] 4.68855e-06
LIS1 [NCBI] 4.68855e-06
DA2B [NCBI] 4.68855e-06
amyloidosis, primary cutaneous [NCBI] 4.68855e-06
osteoporosis, juvenile [NCBI] 4.68855e-06
renal cysts and diabetes syndrome [NCBI] 4.68855e-06
sarcoidosis [NCBI] 4.68855e-06
SNDI [NCBI] 4.68855e-06
gaucher disease, type ii [NCBI] 4.68855e-06
SMA4 [NCBI] 4.68855e-06
SCA6 [NCBI] 4.51846e-06
SSTR2 [NCBI] 4.47953e-06
CPT2 [NCBI] 4.47953e-06
DCX [NCBI] 4.47953e-06
DRD4 [NCBI] 4.44472e-06
TSC2 [NCBI] 4.44472e-06
AMH [NCBI] 4.43906e-06
ADM [NCBI] 4.40768e-06
CDK2 [NCBI] 4.36982e-06
IAPP [NCBI] 4.36982e-06
HBA1 [NCBI] 4.36982e-06
TNC [NCBI] 4.33855e-06
DCK [NCBI] 4.32025e-06
NS1 [NCBI] 4.17033e-06
polycystic kidneys [NCBI] 4.16906e-06
SCIDX1 [NCBI] 4.15791e-06
ARPKD [NCBI] 4.04446e-06
TLR4 [NCBI] 3.93007e-06
PMM2 [NCBI] 3.88059e-06
GFER [NCBI] 3.88059e-06
LHB [NCBI] 3.88059e-06
NUP98 [NCBI] 3.88059e-06
SLC25A20 [NCBI] 3.88059e-06
LDS [NCBI] 3.82248e-06
THC2 [NCBI] 3.82248e-06
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency [NCBI] 3.82248e-06
crouzon syndrome [NCBI] 3.82248e-06
CDGG1 [NCBI] 3.82248e-06
thiopurine s-methyltransferase deficiency [NCBI] 3.82248e-06
mulibrey nanism [NCBI] 3.82248e-06
synovitis, granulomatous, with uveitis and cranial neuropathies [NCBI] 3.82248e-06
autoimmune disease [NCBI] 3.82248e-06
argininosuccinic aciduria [NCBI] 3.82248e-06
septooptic dysplasia [NCBI] 3.82248e-06
NCIE1 [NCBI] 3.82248e-06
spermatogenic failure, nonobstructive, y-linked [NCBI] 3.8075e-06
PI [NCBI] 3.70409e-06
FGFR4 [NCBI] 3.70198e-06
MMP1 [NCBI] 3.70198e-06
SMA1 [NCBI] 3.62725e-06
EXT1 [NCBI] 3.53253e-06
BMP15 [NCBI] 3.53253e-06
APRT [NCBI] 3.52222e-06
VMD [NCBI] 3.46768e-06
JPS [NCBI] 3.46768e-06
DBA [NCBI] 3.46136e-06
ABCB1 [NCBI] 3.36876e-06
PRKAR1A [NCBI] 3.21846e-06
GAS [NCBI] 3.21846e-06
IFNGR1 [NCBI] 3.21846e-06
dubowitz syndrome [NCBI] 3.20601e-06
diaphragmatic hernia, congenital [NCBI] 3.20601e-06
VHL [NCBI] 3.18884e-06
MAG [NCBI] 3.18069e-06
HSAN3 [NCBI] 3.13898e-06
adrenoleukodystrophy, autosomal neonatal form [NCBI] 3.13898e-06
breast cancer [NCBI] 3.11351e-06
LGMD2I [NCBI] 3.08526e-06
CORDX1 [NCBI] 3.08526e-06
COFS1 [NCBI] 3.08526e-06
ACHM2 [NCBI] 3.08526e-06
mitochondrial dna depletion syndrome, hepatocerebral form [NCBI] 3.08526e-06
AGS1 [NCBI] 3.08526e-06
CFEOM1 [NCBI] 3.08526e-06
disorganization, mouse, homolog of [NCBI] 3.08526e-06
erythrocytosis, familial, 2 [NCBI] 3.08526e-06
niemann-pick disease, type b [NCBI] 3.08526e-06
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis [NCBI] 3.08526e-06
SLC6A3 [NCBI] 3.06046e-06
RNASE3 [NCBI] 2.93839e-06
PBP [NCBI] 2.93378e-06
BTK [NCBI] 2.89163e-06
TERT [NCBI] 2.87345e-06
IGER [NCBI] 2.82192e-06
CYP11B2 [NCBI] 2.80126e-06
complement component 6 deficiency [NCBI] 2.80126e-06
TLR2 [NCBI] 2.75821e-06
SMN1 [NCBI] 2.75179e-06
VHL [NCBI] 2.74572e-06
neuraminidase deficiency with beta-galactosidase deficiency [NCBI] 2.67475e-06
glycogen storage disease ixa [NCBI] 2.67475e-06
SKP2 [NCBI] 2.67475e-06
alopecia, androgenetic [NCBI] 2.63075e-06
MEN1 [NCBI] 2.61745e-06
CADASIL [NCBI] 2.56914e-06
KCNH2 [NCBI] 2.55894e-06
HLA-B [NCBI] 2.55386e-06
MAOB [NCBI] 2.55386e-06
DYSF [NCBI] 2.55386e-06
FASN [NCBI] 2.55386e-06
homocystinuria [NCBI] 2.55227e-06
propionic acidemia [NCBI] 2.45844e-06
myasthenic syndrome, congenital, associated with episodic apnea [NCBI] 2.45844e-06
lymphedema-distichiasis syndrome [NCBI] 2.45844e-06
omenn syndrome [NCBI] 2.45844e-06
complement factor h deficiency [NCBI] 2.45844e-06
CRS1 [NCBI] 2.45844e-06
danon disease [NCBI] 2.45844e-06
glutaric acidemia i [NCBI] 2.45844e-06
PAFAH1B1 [NCBI] 2.43829e-06
POU1F1 [NCBI] 2.43829e-06
EWSR1 [NCBI] 2.43829e-06
CFI [NCBI] 2.43829e-06
ARMD1 [NCBI] 2.39516e-06
OPMD [NCBI] 2.35833e-06
CDK6 [NCBI] 2.32771e-06
SPG4 [NCBI] 2.32771e-06
PAEP [NCBI] 2.24523e-06
HHF1 [NCBI] 2.22513e-06
DAP [NCBI] 2.22186e-06
GHRL [NCBI] 2.22186e-06
FHIT [NCBI] 2.22186e-06
PIGA [NCBI] 2.22186e-06
SMA3 [NCBI] 2.2127e-06
MDLS [NCBI] 2.2127e-06
COMP [NCBI] 2.20495e-06
ABCG2 [NCBI] 2.12799e-06
PAI1 [NCBI] 2.12048e-06
XPA [NCBI] 2.02333e-06
PSCA [NCBI] 2.02333e-06
FN1 [NCBI] 2.02333e-06
VIM [NCBI] 2.02077e-06
ALS1 [NCBI] 1.96866e-06
CTNS [NCBI] 1.9467e-06
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity [NCBI] 1.9467e-06
HYPP [NCBI] 1.9467e-06
RUNX2 [NCBI] 1.9302e-06
HDGF [NCBI] 1.9302e-06
SHOX [NCBI] 1.9302e-06
TTP [NCBI] 1.92726e-06
PFIC1 [NCBI] 1.92726e-06
alexander disease [NCBI] 1.92726e-06
severe combined immunodeficiency with sensitivity to ionizing radiation [NCBI] 1.92726e-06
IVA [NCBI] 1.92726e-06
hurler-scheie syndrome [NCBI] 1.92726e-06
INS [NCBI] 1.89014e-06
NOD2 [NCBI] 1.84088e-06
MYOC [NCBI] 1.81359e-06
PG [NCBI] 1.81359e-06
SI [NCBI] 1.81359e-06
SST [NCBI] 1.80736e-06
SMN2 [NCBI] 1.7552e-06
leber optic atrophy [NCBI] 1.7332e-06
lactase persistence [NCBI] 1.68254e-06
CDG1A [NCBI] 1.68254e-06
ATS [NCBI] 1.68254e-06
PCD [NCBI] 1.63913e-06
myoclonic epilepsy of unverricht and lundborg [NCBI] 1.59631e-06
G6PD [NCBI] 1.57017e-06
GLA [NCBI] 1.51824e-06
LPA [NCBI] 1.51824e-06
SCN4A [NCBI] 1.51824e-06
PLAUR [NCBI] 1.48894e-06
SCCMS [NCBI] 1.47975e-06
hyperlipoproteinemia, type i [NCBI] 1.47975e-06
RSMD1 [NCBI] 1.47975e-06
diarrhea 1, secretory chloride, congenital [NCBI] 1.47975e-06
infantile spasm syndrome, x-linked [NCBI] 1.47975e-06
longevity [NCBI] 1.47975e-06
GCPS [NCBI] 1.43343e-06
WFS1 [NCBI] 1.43343e-06
CMTX1 [NCBI] 1.43343e-06
NIDDM [NCBI] 1.43288e-06
HEMB [NCBI] 1.40765e-06
PEDF [NCBI] 1.36931e-06
porphyria cutanea tarda [NCBI] 1.30838e-06
APP [NCBI] 1.24645e-06
DNMT1 [NCBI] 1.24645e-06
CTSC [NCBI] 1.24386e-06
TSC1 [NCBI] 1.24386e-06
SVAS [NCBI] 1.23632e-06
GJB1 [NCBI] 1.20772e-06
HIGM1 [NCBI] 1.20024e-06
campomelic dysplasia [NCBI] 1.20024e-06
FGF23 [NCBI] 1.12231e-06
MLL [NCBI] 1.12231e-06
apc gene [NCBI] 1.11719e-06
EAOH [NCBI] 1.10604e-06
SMEI [NCBI] 1.0973e-06
hemophilia a [NCBI] 1.09192e-06
RP2 [NCBI] 1.06509e-06
MTAP [NCBI] 1.06509e-06
ornithine transcarbamylase deficiency, hyperammonemia due to [NCBI] 1.04792e-06
TTR [NCBI] 1.03928e-06
MAP1B [NCBI] 1.0101e-06
HS [NCBI] 1.0101e-06
isoniazid inactivation [NCBI] 1.0101e-06
CDKN2A [NCBI] 9.97572e-07
PSEN1 [NCBI] 9.92822e-07
SPG4 [NCBI] 9.83904e-07
CMD1A [NCBI] 9.83904e-07
ABP1 [NCBI] 9.68561e-07
CFB [NCBI] 9.57281e-07
HD [NCBI] 9.36683e-07
PRNP [NCBI] 9.2974e-07
FGFR2 [NCBI] 9.2067e-07
B2M [NCBI] 9.06537e-07
RLBP1 [NCBI] 9.06537e-07
PLTP [NCBI] 8.97046e-07
porphyria variegata [NCBI] 8.93819e-07
AR [NCBI] 8.74608e-07
holoprosencephaly [NCBI] 8.63857e-07
ABL1 [NCBI] 8.57797e-07
PROCR [NCBI] 8.57797e-07
MPO [NCBI] 8.52143e-07
MCP [NCBI] 8.27488e-07
CLN2 [NCBI] 7.97924e-07
PKS [NCBI] 7.85444e-07
PARK2 [NCBI] 7.85444e-07
SPG3A [NCBI] 7.85444e-07
PGL1 [NCBI] 7.85444e-07
BRCA2 [NCBI] 7.84817e-07
hla-d histocompatibility type [NCBI] 7.82859e-07
PLK1 [NCBI] 7.8224e-07
IL6 [NCBI] 7.59961e-07
APOE [NCBI] 7.52245e-07
NAT1 [NCBI] 7.22902e-07
SOD1 [NCBI] 7.02765e-07
IGF2 [NCBI] 6.81498e-07
GHR [NCBI] 6.70056e-07
KCNQ1 [NCBI] 6.03678e-07
HMBS [NCBI] 5.90414e-07
danubian endemic familial nephropathy [NCBI] 5.83697e-07
AQP4 [NCBI] 5.67154e-07
KRAS [NCBI] 5.67154e-07
BGLAP [NCBI] 5.50557e-07
STAT1 [NCBI] 5.50557e-07
canavan disease [NCBI] 5.48484e-07
masa syndrome [NCBI] 5.48484e-07
DA2A [NCBI] 5.48484e-07
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive [NCBI] 5.48484e-07
MEN2B [NCBI] 5.48484e-07
porphyria, acute intermittent [NCBI] 5.43632e-07
NF2 [NCBI] 5.32154e-07
FGFR3 [NCBI] 5.01674e-07
RDT [NCBI] 4.97694e-07
hypogonadotropic hypogonadism [NCBI] 4.89938e-07
AGER [NCBI] 4.7118e-07
DNTT [NCBI] 4.66536e-07
exostoses, multiple, type i [NCBI] 4.46729e-07
TBP [NCBI] 4.37496e-07
CD36 [NCBI] 4.0647e-07
GPT [NCBI] 3.78415e-07
pfeiffer syndrome [NCBI] 3.51848e-07
hyperoxaluria, primary, type i [NCBI] 3.51848e-07
REG3A [NCBI] 3.26076e-07
AOS [NCBI] 3.15446e-07
RP3 [NCBI] 3.09046e-07
homocysteinemia [NCBI] 3.09046e-07
FGFR1 [NCBI] 3.03114e-07
SLPI [NCBI] 3.03114e-07
AQP2 [NCBI] 3.01719e-07
RET [NCBI] 2.87727e-07
BCR [NCBI] 2.82823e-07
HBA2 [NCBI] 2.57946e-07
VCP [NCBI] 2.35509e-07
von willebrand disease [NCBI] 2.15832e-07
panencephalitis, subacute sclerosing [NCBI] 2.03621e-07
RTD [NCBI] 2.02982e-07
aortic aneurysm, abdominal [NCBI] 2.02982e-07
pulmonary fibrosis, idiopathic [NCBI] 2.02982e-07
CNC1 [NCBI] 2.02982e-07
PARK2 [NCBI] 1.78957e-07
PTN [NCBI] 1.76913e-07
MAPT [NCBI] 1.76913e-07
APOA1 [NCBI] 1.62123e-07
RYR1 [NCBI] 1.62123e-07
PLG [NCBI] 1.44711e-07
GNRH1 [NCBI] 1.34372e-07
SLC11A2 [NCBI] 1.31329e-07
TPO [NCBI] 1.29638e-07
CMT1B [NCBI] 1.19844e-07
IP [NCBI] 1.18585e-07
phenylketonuria [NCBI] 1.12934e-07
musical perfect pitch [NCBI] 1.04485e-07
HSAS [NCBI] 1.04485e-07
DAR [NCBI] 1.04485e-07
MTR [NCBI] 1.04209e-07
PAM [NCBI] 9.94144e-08
niemann-pick disease, type a [NCBI] 9.75397e-08
MADD [NCBI] 9.75397e-08
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency [NCBI] 9.75397e-08
lynch syndrome i [NCBI] 9.52908e-08
SDS [NCBI] 9.52908e-08
hurler syndrome [NCBI] 8.2199e-08
JAK2 [NCBI] 7.21259e-08
galactosemia [NCBI] 6.35056e-08
AQP1 [NCBI] 6.0301e-08
FBN1 [NCBI] 5.64415e-08
MAOA [NCBI] 5.64415e-08
LS [NCBI] 4.36952e-08
PC [NCBI] 4.23775e-08
FHM1 [NCBI] 4.10844e-08
EVC [NCBI] 4.10844e-08
OKS [NCBI] 4.10844e-08
OPTB1 [NCBI] 4.10844e-08
NRG1 [NCBI] 3.60469e-08
UCP3 [NCBI] 3.57938e-08
LIP [NCBI] 3.1742e-08
glycogen storage disease ib [NCBI] 3.1742e-08
restless legs syndrome, susceptibility to, 1 [NCBI] 3.04654e-08
PIGR [NCBI] 2.48308e-08
GBA [NCBI] 2.32e-08
COMT [NCBI] 2.1128e-08
BL [NCBI] 1.83114e-08
LBP [NCBI] 1.79774e-08
HFE [NCBI] 1.58702e-08
COL2A1 [NCBI] 1.34504e-08
bullous erythroderma ichthyosiformis congenita of brocq [NCBI] 1.25145e-08
antithrombin iii deficiency [NCBI] 6.42453e-09
SMA2 [NCBI] 6.25501e-09
lung cancer [NCBI] 6.25501e-09
pheochromocytoma [NCBI] 6.25501e-09
CCM [NCBI] 4.56825e-09
AN2 [NCBI] 4.56825e-09
FGF1 [NCBI] 3.8975e-09
PBD [NCBI] 2.28333e-09
citrullinemia, classic [NCBI] 2.28333e-09
PDB [NCBI] 2.28333e-09
OFC1 [NCBI] 4.65186e-10
PTHLH [NCBI] 1.78707e-10
ABCB11 [NCBI] 5.27212e-11



Database Center for Life Science